| Company Name: |
NCE Biomedical Co.,Ltd.
|
| Tel: |
4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988 |
| Email: |
|
| Products Intro: |
Product Name:LY2140023
CAS:635318-55-7
Purity:99% HPLC Package:50Mg,100Mg,500Mg,1g,5g,10g,50g,100g,500g,1kg Remarks:XYA0456
|
| Company Name: |
TargetMol Chemicals Inc.
|
| Tel: |
021-021-33632979 15002134094 |
| Email: |
marketing@targetmol.com |
| Products Intro: |
CAS:635318-55-7
Package:100 mg;500 mg Remarks: 90+%，具体纯度信息请见官网
|
| Company Name: |
LETOPHARM LIMITED
|
| Tel: |
+86-21-5821 5861 |
| Email: |
sales@letopharm.com |
| Products Intro: |
Product Name:LY2140023
CAS:635318-55-7
|
| Company Name: |
BOC Sciences
|
| Tel: |
|
| Email: |
info@bocsci.com |
| Products Intro: |
Product Name:LY2140023
CAS:635318-55-7
Purity:98% Remarks:LY2140023 is a prodrug of LY-404039 and a a novel metabotropic glutamate 2/3 receptor agonist peptide prodrug. lt is currently in clinical development as a potential new treatment for schizophrenia. I
|
|
| | LY 2140023 Basic information |
| Product Name: | LY 2140023 | | Synonyms: | PoMagluMetad Methionil;VOYCNOJFAJAILW-CAMHOICYSA-N;LY2140023 monohydrate;2-Thiabicyclo[3.1.0]hexane-4,6-dicarboxylic acid, 4-[[(2S)-2-amino-4-(methylthio)-1-oxobutyl]amino]-, 2,2-dioxide, (1R,4S,5S,6S)-;Pomaglumetad methionil anhydrous | | CAS: | 635318-55-7 | | MF: | C12H18N2O7S2 | | MW: | 366.41 | | EINECS: | | | Product Categories: | | | Mol File: | 635318-55-7.mol |  |
| | LY 2140023 Chemical Properties |
| Melting point | 203 °C | | Boiling point | 773.6±60.0 °C(Predicted) | | density | 1?+-.0.1 g/cm3(Predicted) | | pka | 2.14±0.40(Predicted) |
| | LY 2140023 Usage And Synthesis |
| Uses | LY 2140023 is a drug developed as a treatment option for schizophrenia. It targets the mGlu2/3 receptor once metabolized. |
| | LY 2140023 Preparation Products And Raw materials |
|